Mermel Leonard A, Alang Neha
Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA Division of Infectious Diseases, Rhode Island Hospital, Providence, RI, USA
Department of Medicine, Newport Hospital, Newport, RI, USA.
J Antimicrob Chemother. 2014 Oct;69(10):2611-9. doi: 10.1093/jac/dku182. Epub 2014 Jun 2.
Antimicrobial lock therapy has been widely utilized internationally for the prevention and management of intravascular catheter-related bloodstream infections. One of the agents commonly utilized for lock therapy is ethanol. However, a systematic review of adverse events associated with ethanol locks has not been published.
PubMed was searched to collect articles published from May 2003 through March 2014. The bibliographies of relevant articles were also reviewed.
In vitro studies of the mechanical properties of catheters after ethanol immersion have revealed changes predominantly in polyurethane catheters and to a lesser extent in silicone and Carbothane catheters. An elution of polymers from polyurethane and Carbothane catheters has been observed at the ethanol concentrations used in ethanol lock therapy. Ethanol above a concentration of 28% leads to plasma protein precipitation. Ethanol locks were associated with catheter occlusion in 11 studies and independently increased the risk of thrombosis compared with heparin lock in a randomized trial. Six studies noted abnormalities in catheter integrity, including one case leading to catheter embolization. Of note, five of these studies involved silicone catheters. Ethanol lock use was associated with systemic side effects in 10 studies and possible side effects in one additional study. Four studies noted liver function test abnormalities, predominantly transaminase elevation, related to ethanol lock use. However, a prospective study did not find any difference in the risk of doubling the transaminase level above the normal range during use of ethanol locks compared with not using an ethanol lock.
The use of ethanol locks has been associated with structural changes in catheters, as well as the elution of molecules from the catheter polymers. Clinical studies have revealed systemic toxicity, increased catheter occlusion and breaches in catheter integrity.
抗菌封管疗法已在国际上广泛用于预防和管理血管内导管相关血流感染。封管疗法常用的药物之一是乙醇。然而,尚未发表关于乙醇封管相关不良事件的系统评价。
检索PubMed以收集2003年5月至2014年3月发表的文章。还对相关文章的参考文献进行了审查。
乙醇浸泡后导管机械性能的体外研究表明,主要是聚氨酯导管发生了变化,硅胶和卡波硫因导管的变化较小。在乙醇封管疗法使用的乙醇浓度下,已观察到聚氨酯和卡波硫因导管中有聚合物洗脱。浓度高于28%的乙醇会导致血浆蛋白沉淀。在11项研究中,乙醇封管与导管阻塞有关,在一项随机试验中,与肝素封管相比,乙醇封管独立增加了血栓形成的风险。六项研究指出导管完整性存在异常,包括一例导致导管栓塞的病例。值得注意的是,其中五项研究涉及硅胶导管。在10项研究中,乙醇封管的使用与全身副作用有关,在另一项研究中与可能的副作用有关。四项研究指出肝功能检查异常,主要是转氨酶升高,与乙醇封管的使用有关。然而,一项前瞻性研究发现,与不使用乙醇封管相比,使用乙醇封管期间转氨酶水平高于正常范围加倍的风险没有差异。
乙醇封管的使用与导管结构变化以及导管聚合物中分子的洗脱有关。临床研究显示有全身毒性、导管阻塞增加和导管完整性受损。